missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

MAPKAPK2 Recombinant Human Protein DFS Item

MAPKAPK2 Recombinant Human Protein

Manufacturer:  Life Technologies LSPV4395

 View more versions of this product

Catalog No. PV4395



Description

Description

MARK1 (MARK) is a serine⁄threonine kinase which is involved in cytoskeletal organization and biogenesis
Specifications

Specifications

NP_061120, V618E, T20S
Pharma and biopharma, protein assays and analysis, target and lead identification and validation
MARK1 (MARK) Recombinant Human Protein
10μg
For research use only. Not for use in diagnostic procedures
Serine/threonine kinase
MARK1 (MARK) Recombinant Human Protein
Kinase assay
Baculovirus
MARK1 (MARK) Recombinant Human Protein
Human
0.34mg/mL
116.5kDa
75% by SDS-PAGE
–80°C
1 Each
MARK1 (MARK)
MARK1 (MARK) was pre-diluted in enzyme dilution buffer and assayed in 25mM HEPES (pH 7.5), 10mM MgCl2, 1mM EGTA, 0.5mM Na3VO4, 5mM β-glycerophosphate, 2.5mM DTT, 0.01% Triton™ X-100, 200μM ATP, 333μg/mL CHKtide peptide substrate (KKKVSRSGLYRSPSMPENLNRPR) and trace [32P]-γ-ATP for 10 minutes at 30°C
Kinase and inhibitors
CAMKL
2470nmoles of phosphate transferred to CHKtide peptide substrate (KKKVSRSGLYRSPSMPENLNRPR) per minute per mg of total protein at 30°C. Activity determined at a final protein concentration of 0.83μg/mL
GST Tag
Documents

For Research Use Only. Not for use in diagnostic procedures.